ACTIVE

APOTHEEK ANN-SOPHIE LEROY

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result371,2 k €+84,4 %over 1 year

Gross margin937 k €+54,1 %over 1 year

Equity640,4 k €+0,2 %over 1 year

Workforce7,6 ETP+40,7 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK ANN-SOPHIE LEROY is a Private limited company incorporated in 1996. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Menen. It employs on average 7,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0457.332.432
Incorporation: 15/02/1996
Legal form: Private limited company
Registered office: Ieperstraat 95
8930 Menen · FlandreSee on map
Contributed capital: 18 550,00 €
Latest accounts: 31/12/2025
Average workforce: 7,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47783Other retail sale of new goods in specialised stores 47784Other retail sale of new goods in specialised stores 52488Warehousing and support activities for transportation

Joint committees (2)

313
31300

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	937 k €	+54.1%	608 k €	+25.1%	485,9 k €	+8.0%	449,8 k €	+6.5%	422,4 k €
EBITDA	408,9 k €	+60.9%	254,1 k €	+19.1%	213,4 k €	-9.9%	236,8 k €	+16.0%	204,1 k €
Operating result	365,2 k €	+82.2%	200,4 k €	+20.5%	166,3 k €	-14.3%	194 k €	+21.1%	160,3 k €
Net result	371,2 k €	+84.4%	201,3 k €	+21.8%	165,2 k €	-18.0%	201,5 k €	+29.8%	155,2 k €
Balance sheet
Equity	640,4 k €	+0.2%	639,2 k €	+0.2%	637,9 k €	+0.8%	632,6 k €	+0.2%	631,1 k €
Total assets	1,5 M €	+15.4%	1,3 M €	+18.2%	1,1 M €	+10.3%	1 M €	+0.3%	1 M €
Cash	122,6 k €	+40.7%	87,2 k €	-56.2%	199,2 k €	+14.6%	173,9 k €	-18.0%	212 k €
Debts	871,1 k €	+29.9%	670,6 k €	+42.6%	470,1 k €	+27.0%	370,1 k €	-0.3%	371,1 k €
Other
Workforce	7,6 ETP	+40.7%	5,4 ETP	+25.6%	4,3 ETP	+7.5%	4,0 ETP	0.0%	4,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 16 ended

Active mandates

Ansopharma

Director · since 01 novembre 2017 · 0683.639.271

Represented by Leroy Ann-Sophie

Active

Ended mandates

Ansopharma

Manager · since 01 novembre 2017 · 0683.639.271

Represented by Ann-Sophie Leroy

Ended

Caroline Van Hollebeke

Manager · since 01 janvier 2013 · until 31 décembre 2013

Ended

DEAL BVBA

Manager · since 22 mars 2012 · 0810.777.567

Represented by Ann-Sophie Leroy

Ended

Ann-Sophie Leroy

Manager · until 31 octobre 2017

Ended

Other companies at this address

Ieperstraat 95 8930 Menen

Company	CBE no.
Ansopharma● Active	0683.639.271
DEMA● Active	0667.773.041
GROEP LEROY● Active	0687.545.205
PROREDAR● Active	0442.429.074

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/07/2026	29/08/2025	30/07/2024	14/07/2023	17/10/2022	11/10/2021
General meeting	24/06/2026	25/06/2025	26/06/2024	28/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/06/2026	22/07/2026	Dutch	PDF
Abridged model	31/12/2024	25/06/2025	29/08/2025	Dutch	PDF
Abridged model	31/12/2023	26/06/2024	30/07/2024	Dutch	PDF
Abridged model	31/12/2022	28/06/2023	14/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	17/10/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	11/10/2021	Dutch	PDF
Abridged model	31/12/2019	24/06/2020	24/07/2020	Dutch	PDF
Abridged model	31/12/2018	26/06/2019	13/08/2019	Dutch	PDF
Abridged model	31/12/2017	27/06/2018	10/10/2018	Dutch	PDF
Abridged model	31/12/2016	07/06/2017	30/06/2017	Dutch	PDF
Abridged model	31/12/2015	08/06/2016	05/07/2016	Dutch	PDF
Abridged model	31/12/2014	10/06/2015	03/07/2015	Dutch	PDF
Abridged model	31/12/2013	11/06/2014	09/07/2014	Dutch	PDF
Abridged model	31/12/2012	26/06/2013	23/07/2013	Dutch	PDF
Abridged model	31/12/2011	16/05/2012	12/06/2012	Dutch	PDF
Abridged model	31/12/2010	17/08/2011	24/08/2011	Dutch	PDF
Abridged model	31/12/2009	09/06/2010	08/07/2010	Dutch	PDF
Abridged model	31/12/2008	20/05/2009	18/06/2009	Dutch	PDF
Abridged model	31/12/2007	22/07/2008	14/08/2008	Dutch	PDF
Abridged model	31/12/2006	06/06/2007	29/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 16 ended

Active mandates

Ansopharma

Director · since 01 novembre 2017 · 0683.639.271

Represented by Leroy Ann-Sophie

Active

Ended mandates

Ansopharma

Manager · since 01 novembre 2017 · 0683.639.271

Represented by Ann-Sophie Leroy

Ended

Caroline Van Hollebeke

Manager · since 01 janvier 2013 · until 31 décembre 2013

Ended

DEAL BVBA

Manager · since 22 mars 2012 · 0810.777.567

Represented by Ann-Sophie Leroy

Ended

Ann-Sophie Leroy

Manager · until 31 octobre 2017

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates03/05/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates11/01/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/08/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/07/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/04/2012
BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates10/09/2008
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/07/2008
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares25/06/2007
KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025371,2 k €↑
2024
Annual accounts 2024201,3 k €↑
2023
Annual accounts 2023165,2 k €↓
2022
Annual accounts 2022201,5 k €↑
2021
Annual accounts 2021155,2 k €↓
2018
Annual accounts 2018230,3 k €↑
2017
Annual accounts 2017164,2 k €↑
2016
Annual accounts 201699 k €↓
2015
Annual accounts 2015116,1 k €↑
2014
Annual accounts 201498,1 k €↑
2013
Annual accounts 201360,2 k €↓
2012
Annual accounts 2012106,8 k €↑
2011
Annual accounts 201195,7 k €↑
2010
Annual accounts 20104,5 k €↑
2009
Annual accounts 2009-8,3 k €↓
2008
Annual accounts 200836,5 k €↓
2007
Annual accounts 200771,3 k €↓
2006
Annual accounts 200675,2 k €
15/02/1996
IncorporationPrivate limited company

APOTHEEK ANN-SOPHIE LEROY

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline